Belkhir Leïla, M.D., Ph.D

Belkhir Leïla, M.D., Ph.D

Université Catholique de Louvain

H-index: 25

Europe-Belgium

About Belkhir Leïla, M.D., Ph.D

Belkhir Leïla, M.D., Ph.D, With an exceptional h-index of 25 and a recent h-index of 22 (since 2020), a distinguished researcher at Université Catholique de Louvain, specializes in the field of Maladies infectieuses, HIV, Médecine du voyage, infections intraabdominales, pharmacogénomique.

His recent articles reflect a diverse array of research interests and contributions to the field:

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Imported Asymptomatic Schistosomiasis Among Belgian School Travelers to Rwanda: a Case Series

Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Innovations 2023 en Biologie Hématologique

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Innovations 2023 en cardiologie

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

Belkhir Leïla, M.D., Ph.D Information

University

Position

Cliniques universtaires Saint-Luc Belgium

Citations(all)

3056

Citations(since 2020)

2815

Cited By

693

hIndex(all)

25

hIndex(since 2020)

22

i10Index(all)

53

i10Index(since 2020)

49

Email

University Profile Page

Université Catholique de Louvain

Google Scholar

View Google Scholar Profile

Belkhir Leïla, M.D., Ph.D Skills & Research Interests

Maladies infectieuses

HIV

Médecine du voyage

infections intraabdominales

pharmacogénomique

Top articles of Belkhir Leïla, M.D., Ph.D

Title

Journal

Author(s)

Publication Date

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

The Lancet HIV

Chloe Orkin

Jean-Michel Molina

Pedro Cahn

Johannes Lombaard

Khuanchai Supparatpinyo

...

2024/2/1

Imported Asymptomatic Schistosomiasis Among Belgian School Travelers to Rwanda: a Case Series

Frontiers in Tropical Diseases

Silvio Wallemacq

Ahalieyah Anantharajah

Pamela Baldin

Jean-Cyr Yombi

Julien De Greef

...

2024/3/20

Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium

Annales d'endocrinologie

Thomas Servais

France Laurent

Thomas Roland

Camelia Rossi

Elodie De Groote

...

2024/2/1

Identification of a newly emerging second-generation HIV-1 circulating recombinant form (CRF145_0755) among men who have sex with men in China

Journal of Infection

Yanling Ma

Huichao Chen

Jie Dai

Lijuan Dong

Manhong Jia

2024/3/1

Innovations 2023 en Biologie Hématologique

Louvain médical

Madeleine Rousseaux

Jean Cyr Yombi

Leïla Belkhir

Julien De Greef

Andrea Penaloza-Baeza

...

2024

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial

Journal of Infection

Maya Hites

Eva Larranaga Lapique

Clément R Massonnaud

Drifa Belhadi

Simon Jamard

...

2024/3/1

Innovations 2023 en cardiologie

Louvain médical

Agnes Pasquet

Laurence Bamps

Leïla Belkhir

Mélanie Dechamps

Julien De Greef

...

2024

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

EClinicalMedicine

Ilias I Siempos

Andre C Kalil

Drifa Belhadi

Viviane Cordeiro Veiga

Alexandre Biasi Cavalcanti

...

2024/3/1

Innovations 2023 en médecine interne et maladies infectieuses

Louvain médical

Laurence Bamps

Leïla Belkhir

Julien De Greef

Anne Vincent

Jean Cyr Yombi

2024

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature communications

Cathrine Axfors

Andreas M Schmitt

Perrine Janiaud

Janneke van’t Hooft

Sherief Abd-Elsalam

...

2024/2/5

Secondary organizing pneumonia associated with protracted COVID: A case series

Infectious diseases now

Pierre-Yves Sansen

Emmanuel Coche

Philippe Hainaut

Antoine Froidure

Anaïs Scohy

...

2024/4/1

Deep plasma proteomics with data-independent acquisition: A fastlane towards biomarkers identification.

bioRxiv

Bradley Ward

Sebastien Pyr dit Ruys

Jean-Luc Balligand

Leila Belkhir

Patrice D Cani

...

2024

Impact of the COVID-19 pandemic on Clostridioides difficile infection in a tertiary healthcare institution in Belgium

Acta Clinica Belgica

Bastien Tossens

Philippe Barthelme

Caroline Briquet

Leila Belkhir

Eléonore Ngyuvula

...

2023/11/2

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

The Lancet

George R Thompson

Alex Soriano

Oliver A Cornely

Bart Jan Kullberg

Marin Kollef

...

2023/1/7

There Is a Risk of Spread During a Nebulization Session in a Patient with COVID-19

Journal of aerosol medicine and pulmonary drug delivery

Christophe Thibon

Laurent Vecellio

Leila Belkhir

Jean-Christophe Dubus

Annie Robert

...

2023/10/1

A Case Report of Safe Coadministration of Amiodarone with Short-Term Treatment Nirmatrelvir-Ritonavir

Clinical pharmacology and therapeutics

Alice Sluijters

Florian Lemaitre

Leïla Belkhir

Lidvine Boland

Vincent Haufroid

...

2023

Nebulization and COVID-19: the risk of spread during a nebulization session is actual

Christophe Thibon

Laurent Vecellio

Leila Belkhir

Jean-Christophe Dubus

Annie Robert

...

2023/9/9

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination

Heliyon

Imane Saad Albichr

Samy Mzougui

Arnaud Devresse

Hélène Georgery

Eric Goffin

...

2023/6/1

Streptococcus Pneumoniae Bacteremia with Acute Kidney Injury and Transient ADAMTS13 Deficiency

Case reports in infectious diseases

Sam Van Hove

Alexis Werion

Ahalieyah Anantharajah

Leila Belkhir

Marie-Astrid van Dievoet

...

2023/4/29

MONKEYPOX MULTI-COUNTRY OUTBREAK, 2022

UPDATE

Tinne Lernout

Yves Lafort

Valeska Laisnez

Sabine Allard

Leïla Belkhir

...

2022

See List of Professors in Belkhir Leïla, M.D., Ph.D University(Université Catholique de Louvain)